Stock RNAZ TRANSCODE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. TransCode Therapeutics, Inc.

Equities

RNAZ

US89357L3033

Real-time Estimate Cboe BZX
Other stock markets
 10:11:04 2024-07-11 am EDT 		5-day change 1st Jan Change
0.929 USD +3.22% Intraday chart for TransCode Therapeutics, Inc. +21.04% -86.04%
May. 29 TransCode Therapeutics, Inc. Reports Positive Data from First-In-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138 CI
May. 15 TransCode Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
HC Wainwright Adjusts Price Target on TransCode Therapeutics to $6 From $10, Maintains Buy Rating
MT
HC Wainwright Starts TransCode Therapeutics at Buy With $10 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RNAZ Stock
  4. News TransCode Therapeutics, Inc.
  5. Analyst Reco.